Plus   Neg

Osiris Therapeutics Inc. (OSIR) Surged To A 2-Month High On Q4 Results

Osiris Therapeutics Inc. (OSIR) reported a fourth quarter loss of $0.08 per share Wednesday morning, compared to the profit of $0.15 per share last year. The consensus estimate was for a loss of $0.15.

Osiris Therapeutics gapped open sharply higher Wednesday and climbed in early trade, before settling into a narrow range. Shares finished up by 2.44 at $9.35, with volume at an 8-month high. The stock surged to a 2-month high and re-crossed both its 50 and 200-day moving averages.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Follow RTT